These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


399 related items for PubMed ID: 11018164

  • 1. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators.
    Lallemant M, Jourdain G, Le Coeur S, Kim S, Koetsawang S, Comeau AM, Phoolcharoen W, Essex M, McIntosh K, Vithayasai V.
    N Engl J Med; 2000 Oct 05; 343(14):982-91. PubMed ID: 11018164
    [Abstract] [Full Text] [Related]

  • 2. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL.
    N Engl J Med; 1994 Nov 03; 331(18):1173-80. PubMed ID: 7935654
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
    Thistle P, Spitzer RF, Glazier RH, Pilon R, Arbess G, Simor A, Boyle E, Chitsike I, Chipato T, Gottesman M, Silverman M.
    Clin Infect Dis; 2007 Jan 01; 44(1):111-9. PubMed ID: 17143826
    [Abstract] [Full Text] [Related]

  • 4. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.
    Wade NA, Birkhead GS, Warren BL, Charbonneau TT, French PT, Wang L, Baum JB, Tesoriero JM, Savicki R.
    N Engl J Med; 1998 Nov 12; 339(20):1409-14. PubMed ID: 9811915
    [Abstract] [Full Text] [Related]

  • 5. Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.
    Limpongsanurak S, Thaithumyanon P, Chaithongwongwatthana S, Thisyakorn U, Ruxrungtham K, Kongsin P, Tarounotai U, Chantheptaewan N, Triratwerapong T, Ubolyam S, Phanuphak P, Virutamasen P, Hanwanich M, Hawanon P, Chulasugondha P.
    J Med Assoc Thai; 2001 Jun 12; 84 Suppl 1():S338-45. PubMed ID: 11529355
    [Abstract] [Full Text] [Related]

  • 6. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.
    Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, McSherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL.
    N Engl J Med; 1996 Nov 28; 335(22):1621-9. PubMed ID: 8965861
    [Abstract] [Full Text] [Related]

  • 7. Growth of human immunodeficiency virus-uninfected children exposed to perinatal zidovudine for the prevention of mother-to-child human immunodeficiency virus transmission.
    Briand N, Le Coeur S, Traisathit P, Karnchanamayul V, Hansudewechakul R, Ngampiyasakul C, Bhakeecheep S, Ithisukanan J, Hongsiriwon S, McIntosh K, Lallemant M.
    Pediatr Infect Dis J; 2006 Apr 28; 25(4):325-32. PubMed ID: 16567984
    [Abstract] [Full Text] [Related]

  • 8. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission--Thailand, 1996-1998.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1998 Mar 06; 47(8):151-4. PubMed ID: 9518278
    [Abstract] [Full Text] [Related]

  • 9. A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
    Moodley D, Moodley J, Coovadia H, Gray G, McIntyre J, Hofmyer J, Nikodem C, Hall D, Gigliotti M, Robinson P, Boshoff L, Sullivan JL, South African Intrapartum Nevirapine Trial (SAINT) Investigators.
    J Infect Dis; 2003 Mar 01; 187(5):725-35. PubMed ID: 12599045
    [Abstract] [Full Text] [Related]

  • 10. From research to practice: use of short course zidovudine to prevent mother-to-child HIV transmission in the context of routine health care in Northern Thailand.
    Thaineua V, Sirinirund P, Tanbanjong A, Lallemant M, Soucat A, Lamboray JL.
    Southeast Asian J Trop Med Public Health; 1998 Sep 01; 29(3):429-42. PubMed ID: 10437936
    [Abstract] [Full Text] [Related]

  • 11. Influence of mother and infant zidovudine treatment duration on the age at which HIV infection can be detected by polymerase chain reaction in infants.
    Prasitwattanaseree S, Lallemant M, Costagliola D, Jourdain G, Mary JY.
    Antivir Ther; 2004 Apr 01; 9(2):179-85. PubMed ID: 15134179
    [Abstract] [Full Text] [Related]

  • 12. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
    Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V, Perinatal HIV Prevention Trial (Thailand) Investigators.
    N Engl J Med; 2004 Jul 15; 351(3):217-28. PubMed ID: 15247338
    [Abstract] [Full Text] [Related]

  • 13. A randomized control trial of an Ultra-Short zidovudine regimen in the prevention of perinatal HIV transmission in rural Zimbabwe.
    Thistle P, Gottesman M, Pilon R, Glazier RH, Arbess G, Phillips E, Wald RL, Chitsike I, Simor A, Chipato T, Silverman M.
    Cent Afr J Med; 2004 Jul 15; 50(9-10):79-84. PubMed ID: 16411341
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.
    Jourdain G, Mary JY, Coeur SL, Ngo-Giang-Huong N, Yuthavisuthi P, Limtrakul A, Traisathit P, McIntosh K, Lallemant M, Perinatal HIV Prevention Trial Group, Thailand.
    J Infect Dis; 2007 Dec 01; 196(11):1629-36. PubMed ID: 18008246
    [Abstract] [Full Text] [Related]

  • 16. Short-course therapy with zidovudine plus lamivudine for prevention of mother-to-child transmission of human immunodeficiency virus type 1 in Thailand.
    Chaisilwattana P, Chokephaibulkit K, Chalermchockcharoenkit A, Vanprapar N, Sirimai K, Chearskul S, Sutthent R, Opartkiattikul N.
    Clin Infect Dis; 2002 Dec 01; 35(11):1405-13. PubMed ID: 12439805
    [Abstract] [Full Text] [Related]

  • 17. Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.
    Chalermchockcharoenkit A, Culnane M, Chotpitayasunondh T, Vanprapa N, Leelawiwat W, Mock PA, Asavapiriyanont S, Teeraratkul A, McConnell MS, McNicholl JM, Tappero JW.
    Clin Infect Dis; 2009 Jul 15; 49(2):299-305. PubMed ID: 19522656
    [Abstract] [Full Text] [Related]

  • 18. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.
    PLoS Med; 2007 Aug 15; 4(8):e257. PubMed ID: 17713983
    [Abstract] [Full Text] [Related]

  • 19. Intrapartum and neonatal zidovudine treatment in reduction of perinatal HIV-1 transmission in Bangkok.
    Thaithumyanon P, Thisyakorn U, Limpongsanurak S, Chaithongwongwatthana S, Punnahitanon S, Ubolyam S, Phanuphak P, Ruxrungtham K, Virutamasen P.
    J Med Assoc Thai; 2001 Sep 15; 84(9):1229-34. PubMed ID: 11800293
    [Abstract] [Full Text] [Related]

  • 20. Abbreviated AZT regimen is effective in curbing HIV in infants.
    AIDS Policy Law; 1998 Mar 06; 13(4):7. PubMed ID: 11365164
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.